BeiGene

NCT07296705

CollaboratorPhase 2Recruiting202525 people22 Dec 2025clinicaltrials.gov

NCT06730542

CollaboratorPhase 1Recruiting202520 people12 Dec 2024clinicaltrials.gov

NCT05635708

Phase 2Active, not recruiting2023400 people2 Dec 2022clinicaltrials.gov

NCT05577702

Phase 2Completed2023121 people13 Oct 2022clinicaltrials.gov

NCT05014815

Phase 2Completed2021272 people20 Aug 2021clinicaltrials.gov

NCT04974047

Phase 2Completed202170 people23 Jul 2021clinicaltrials.gov

NCT04649385

Phase 1Completed2021157 people2 Dec 2020clinicaltrials.gov

NCT04379635

Phase 3Active, not recruiting2020453 people7 May 2020clinicaltrials.gov

NCT04047862

Phase 1Completed2019446 people7 Aug 2019clinicaltrials.gov

NCT04005716

Phase 3Completed2019457 people2 Jul 2019clinicaltrials.gov

NCT03967977

Phase 3Active, not recruiting2019420 people30 May 2019clinicaltrials.gov

NCT03957590

Phase 3Completed2019370 people21 May 2019clinicaltrials.gov

NCT03924986

Phase 3Completed2019263 people23 Apr 2019clinicaltrials.gov

NCT03783442

Phase 3Completed2018649 people21 Dec 2018clinicaltrials.gov

NCT03777657

Phase 3Completed2018997 people17 Dec 2018clinicaltrials.gov

NCT03663205

Phase 3Completed2018334 people10 Sept 2018clinicaltrials.gov

NCT03432598

Phase 2Completed201754 people14 Feb 2018clinicaltrials.gov

NCT03412773

Phase 3Completed2017684 people26 Jan 2018clinicaltrials.gov